{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,4]],"date-time":"2026-04-04T01:43:04Z","timestamp":1775266984958,"version":"3.50.1"},"reference-count":25,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1016\/j.ejpb.2021.03.009","type":"journal-article","created":{"date-parts":[[2021,3,23]],"date-time":"2021-03-23T12:46:26Z","timestamp":1616503586000},"page":"99-104","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["The potential of porcine ex vivo platform for intestinal permeability screening of FcRn-targeted drugs"],"prefix":"10.1016","volume":"162","author":[{"given":"Cl\u00e1udia","family":"Azevedo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan Terje","family":"Andersen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giovanni","family":"Traverso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bruno","family":"Sarmento","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejpb.2021.03.009_b0005","series-title":"Nanotechnology for Oral Drug Delivery","first-page":"389","author":"Almeida","year":"2020"},{"issue":"5","key":"10.1016\/j.ejpb.2021.03.009_b0010","first-page":"544","article-title":"Robotically handled whole-tissue culture system for the screening of oral drug formulations, Nature","volume":"4","author":"von Erlach","year":"2020","journal-title":"Biomed. Eng."},{"key":"10.1016\/j.ejpb.2021.03.009_b0015","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1172\/JCI6968","article-title":"Bidirectional FcRn-dependent IgG transport in a polarized human intestinal epithelial cell line","volume":"104","author":"Dickinson","year":"1999","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.ejpb.2021.03.009_b0020","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1002\/jps.21010","article-title":"Variability in Caco-2 and MDCK Cell-Based Intestinal Permeability Assays","volume":"97","author":"Volpe","year":"2008","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2021.03.009_b0025","doi-asserted-by":"crossref","first-page":"7812","DOI":"10.1074\/jbc.M113.537563","article-title":"Structural insights into neonatal Fc receptor-based recycling mechanisms","volume":"289","author":"Oganesyan","year":"2014","journal-title":"J. biological chemistry"},{"key":"10.1016\/j.ejpb.2021.03.009_b0030","doi-asserted-by":"crossref","first-page":"14649","DOI":"10.1021\/bi00045a005","article-title":"Analysis of the pH Dependence of the Neonatal Fc Receptor\/Immunoglobulin G Interaction Using Antibody and Receptor Variants","volume":"34","author":"Raghavan","year":"1995","journal-title":"Biochemistry"},{"key":"10.1016\/j.ejpb.2021.03.009_b0035","doi-asserted-by":"crossref","first-page":"4826","DOI":"10.1074\/jbc.M109.081828","article-title":"Cross-species binding analyses of mouse and human neonatal Fc receptor show dramatic differences in immunoglobulin G and albumin binding","volume":"285","author":"Andersen","year":"2010","journal-title":"J. biological chemistry"},{"key":"10.1016\/j.ejpb.2021.03.009_b0040","doi-asserted-by":"crossref","first-page":"5171","DOI":"10.4049\/jimmunol.169.9.5171","article-title":"Increasing the Affinity of a Human IgG1 for the Neonatal Fc Receptor: Biological Consequences","volume":"169","author":"Acqua","year":"2002","journal-title":"J. Immunol."},{"issue":"9","key":"10.1016\/j.ejpb.2021.03.009_b0045","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1038\/nri2155","article-title":"FcRn: the neonatal Fc receptor comes of age","volume":"7","author":"Roopenian","year":"2007","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.ejpb.2021.03.009_b0050","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1038\/ncomms1607","article-title":"Structure-based mutagenesis reveals the albumin-binding site of the neonatal Fc receptor","volume":"3","author":"Andersen","year":"2012","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ejpb.2021.03.009_b0055","doi-asserted-by":"crossref","unstructured":"A.R. Mezo, K.A. McDonnell, C.A. Hehir, S.C. Low, V.J. Palombella, J.M. Stattel, G.D. Kamphaus, C. Fraley, Y. Zhang, J.A. Dumont, A.J. Bitonti, Reduction of IgG in nonhuman primates by a peptide antagonist of the neonatal Fc receptor FcRn, Proceedings of the National Academy of Sciences of the United States of America, 105 (2008) 2337-2342.","DOI":"10.1073\/pnas.0708960105"},{"key":"10.1016\/j.ejpb.2021.03.009_b0060","first-page":"1","article-title":"Boosting therapeutic potency of antibodies by taming Fc domain functions","volume":"51","author":"Kang","year":"2019","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.ejpb.2021.03.009_b0065","doi-asserted-by":"crossref","first-page":"213ra167","DOI":"10.1126\/scitranslmed.3007049","article-title":"Transepithelial transport of Fc-targeted nanoparticles by the neonatal fc receptor for oral delivery","volume":"5","author":"Pridgen","year":"2013","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.ejpb.2021.03.009_b0070","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1038\/s41598-018-19170-y","article-title":"Fc-modified exenatide-loaded nanoparticles for oral delivery to improve hypoglycemic effects in mice","volume":"8","author":"Shi","year":"2018","journal-title":"Sci. Rep."},{"issue":"27","key":"10.1016\/j.ejpb.2021.03.009_b0075","doi-asserted-by":"crossref","first-page":"1800462","DOI":"10.1002\/smll.201800462","article-title":"Engineered Multifunctional Albumin-Decorated Porous Silicon Nanoparticles for FcRn Translocation of Insulin","volume":"14","author":"Martins","year":"2018","journal-title":"Small"},{"key":"10.1016\/j.ejpb.2021.03.009_b0080","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.jconrel.2020.08.005","article-title":"Engineered albumin-functionalized nanoparticles for improved FcRn binding enhances oral delivery of insulin","volume":"327","author":"Azevedo","year":"2020","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejpb.2021.03.009_b0085","unstructured":"J. Cameron, D. Sleep, J. T. Andersen, I. Sandlie, Pharmacokinetic animal model, patent US 2016\/0033523 A1, (2016)."},{"key":"10.1016\/j.ejpb.2021.03.009_b0090","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1111\/j.1365-2567.2004.02121.x","article-title":"Characterization of the porcine neonatal Fc receptor\u2013potential use for trans-epithelial protein delivery","volume":"114","author":"Stirling","year":"2005","journal-title":"Immunology"},{"key":"10.1016\/j.ejpb.2021.03.009_b0095","first-page":"1089","article-title":"Tissues Expression, Polymorphisms Identification of FcRn Gene and Its Relationship with Serum Classical Swine Fever Virus Antibody Level in Pigs, Asian-Australas","volume":"25","author":"Yang","year":"2012","journal-title":"J. Anim. Sci."},{"key":"10.1016\/j.ejpb.2021.03.009_b0100","first-page":"183","article-title":"Intraluminal pH of the human gastrointestinal tract","volume":"46","author":"Fallingborg","year":"1999","journal-title":"Dan. Med. Bull."},{"key":"10.1016\/j.ejpb.2021.03.009_b0105","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1016\/0016-5085(86)90873-5","article-title":"Intraluminal pH in the stomach, duodenum, and proximal jejunum in normal subjects and patients with exocrine pancreatic insufficiency","volume":"90","author":"Ovesen","year":"1986","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ejpb.2021.03.009_b0110","unstructured":"C. Azevedo, I. Pereira, B. Sarmento, Intestinal mucosal models to validate functionalized nanosystems, in: A. Fahr, et al., Characterization of Pharmaceutical Nano- and Microsystems, Wiley, 2020, 978-1-119-41404-9."},{"key":"10.1016\/j.ejpb.2021.03.009_b0115","doi-asserted-by":"crossref","first-page":"13492","DOI":"10.1074\/jbc.M114.549832","article-title":"Extending serum half-life of albumin by engineering neonatal Fc receptor (FcRn) binding","volume":"289","author":"Andersen","year":"2014","journal-title":"J. biological chemistry"},{"key":"10.1016\/j.ejpb.2021.03.009_b0120","doi-asserted-by":"crossref","unstructured":"J. Westerhout, E.v.d. Steeg, D. Grossouw, E.E. Zeijdner, C.A.M. Krul, M. Verwei, H.M. Wortelboer, A new approach to predict human intestinal absorption using porcine intestinal tissue and biorelevant matrices, European Journal of Pharmaceutical Sciences, 63 (2014) 167-177.","DOI":"10.1016\/j.ejps.2014.07.003"},{"issue":"5","key":"10.1016\/j.ejpb.2021.03.009_b0125","doi-asserted-by":"crossref","DOI":"10.1002\/prp2.522","article-title":"Jejunal wall delivery of insulin via an ingestible capsule in anesthetized swine-A pharmacokinetic and pharmacodynamic study","volume":"7","author":"Hashim","year":"2019","journal-title":"Pharmacol. Res. Perspect."}],"container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641121000746?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641121000746?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T16:42:16Z","timestamp":1760546536000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0939641121000746"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5]]},"references-count":25,"alternative-id":["S0939641121000746"],"URL":"https:\/\/doi.org\/10.1016\/j.ejpb.2021.03.009","relation":{},"ISSN":["0939-6411"],"issn-type":[{"value":"0939-6411","type":"print"}],"subject":[],"published":{"date-parts":[[2021,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The potential of porcine ex vivo platform for intestinal permeability screening of FcRn-targeted drugs","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutics and Biopharmaceutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejpb.2021.03.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}